Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
776b587NSSapcyHA
Listen
